0001209191-20-019800.txt : 20200317 0001209191-20-019800.hdr.sgml : 20200317 20200317192955 ACCESSION NUMBER: 0001209191-20-019800 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200315 FILED AS OF DATE: 20200317 DATE AS OF CHANGE: 20200317 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Steven James CENTRAL INDEX KEY: 0001598763 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34877 FILM NUMBER: 20722677 MAIL ADDRESS: STREET 1: 1050 17TH STREET, SUITE 800 CITY: DENVER STATE: CO ZIP: 80265 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoreSite Realty Corp CENTRAL INDEX KEY: 0001490892 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1001 17TH STREET STREET 2: SUITE 500 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: (866) 777-2673 MAIL ADDRESS: STREET 1: 1001 17TH STREET STREET 2: SUITE 500 CITY: DENVER STATE: CO ZIP: 80202 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-15 0 0001490892 CoreSite Realty Corp COR 0001598763 Smith Steven James C/O CORESITE REALTY CORPORATION 1001 17TH STREET, SUITE 500 DENVER CO 80202 0 1 0 0 Chief Revenue Officer Common Stock 2020-03-15 4 A 0 6523 0.00 A 42910 D Common Stock 2020-03-15 4 A 0 7610 0.00 A 50520 D Common Stock 2020-03-16 4 S 0 89 94.76 D 50431 D Common Stock 2020-03-16 4 S 0 90 96.33 D 50341 D Common Stock 2020-03-16 4 S 0 174 98.37 D 50167 D Common Stock 2020-03-16 4 S 0 294 100.66 D 49873 D Common Stock 2020-03-16 4 S 0 737 101.69 D 49136 D Common Stock 2020-03-16 4 S 0 428 103.11 D 48708 D Common Stock 2020-03-16 4 S 0 26 103.96 D 48682 D Common Stock 2020-03-16 4 S 0 90 105.23 D 48592 D Represents restricted stock granted under the issuer's 2010 Equity Incentive Award Plan (the "2010 Plan"). The restricted stock vests in three equal annual installments beginning on March 15, 2021, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Represents performance-based restricted shares ("PSAs") granted under the 2010 Plan. The number of PSAs earned is based on the issuer's achievement of relative total shareholder return ("TSR") measured versus the MSCI US REIT Index over a three-year performance period ending December 31, 2022, and the number of shares earned may range from 25% to 175%. The PSAs are earned as follows: (i) 20% of the PSAs are earned upon TSR achievement in year one of the performance period, (ii) 20% of the PSAs are earned upon TSR achievement in year two of the performance period, (iii) 20% of the PSAs are earned upon TSR achievement in year three of the performance period, and (iv) 40% of the PSAs are earned upon a cumulative TSR achievement over the three-year performance period, subject to the reporting person's continued service with the issuer at the end of the three-year performance period. The PSAs are granted and issued at 175% of the target amount. The shares were sold pursuant to a sales plan adopted by the reporting person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.00 to $96.35, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 5 through 10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.26 to $98.47, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.27 to $101.03, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.38 to $102.18, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $102.44 to $103.34, inclusive. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $103.96 to $103.97, inclusive. /s/ Derek S. McCandless, Attorney-in-Fact 2020-03-17